No Detail Found!

Is Serum Albumin An Independent Predictor of Post Chemotherapy Febrile Neutropenia?.

Author(s)
Lubna Saleem Liaquat National Hospital KarachiPakistan
Naila Anjum Zahid Liaquat National Hospital KarachiPakistan
Abstract
Objective: To evaluate the association between serum albumin and risk of post chemotherapy febrile neutropenia. Study Design: Cross sectional study. Place and Duration of Study: Department of oncology, Liaquat National Hospital, from 1st Jan 2015 to 31st Dec 2016. Material and Method: One hundred and sixty-six biopsy proven cancer patients with Eastern cooperative oncology group (ECOG) performance status <2 and without significant co-morbidities received first cycle of chemotherapy during two years study period. Different chemotherapies with moderate to severe risk of FN were used. Patient's pre-treatment serum albumin was measured and patients followed for occurrence of FN. Association between serum albumin and post chemotherapy FN was analyzed. Results: Data of 166 patients was available for final analysis. Post chemotherapy FN was observed in 19.9% (33/166) patients. Pre-chemotherapy serum albumin level was <3.5 mg/dl in (35/166) 21.1% of patients, out of which (15/35) 42.9% developed FN. Serum albumin (p=0.0005) was highly significantly associated with a risk of FN. On analysis of other factors age, gender, body surface area (BSA) and pre-chemotherapy hemoglobin level were not significantly associated with a risk of FN while body mass index (p=0.0005) was found to be associated with risk of FN. Conclusion: Pre-chemotherapy serum albumin levels were found to be statistically significant predictor of postchemotherapy febrile neutropenia.
Publication Details
Page(s) 768-774
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 67, Issue: 5, Year: 2017

Request the full text from PASTIC

References
ChelenzS,GilesD,AbdallahSE,,2012,Pidemiology, management and economic impact of febrile neutropenia in oncology patients receiving route care at a regional UK cancer centre,Ann Oncol,23,1889,93
SmithTJ,BohlkeK,LymanGH,,2015,Recommendations for the use of WBC growth factors: American Society of clinical oncology clinical practice guideline update,J Clin Oncol,33,3199,212
PathakR,GiriS,AryalMR,KarmacharyaP,BhattVR,MartinM,,2015,Mortality, length of stay and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in united states,Support Care Cancer,23,615,17
LymanGH,,2009,Impact of chemotherapy dose intensity on cancer patient outcomes,J Natl Compr Canc Netw,7,99,108
CulakovaE,ThotaR,PoniewierskiMS,KudererNM,WoguAF,,2014,Patterns of nation-wide prospective cohort,Cancer Med,3,434,44
LymanGH,AbellaE,PettengellR,,2014,Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review,Crit Rev Oncol Hematol,90,190,9
TakumiF,HirotsuguK,TateakiN,TakahisaK.,,2017,The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum,Cancer Chemotherpy and Pharmacology,79,1229,37
JenkinsP,ScaifeJ,FreemanS.,,2012,Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer,Ann Oncol,23,1766,71
EvaC,MarekSP,DebraAW,DavidCD,CrawfordJ,LymanGH,,2015,The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: A prospective cohort study,Springer plus,4,396,
ThomasJ,SmithTJ,BohlkeK,LymanGH,KennethR,CrawfordJ,,2015,Recommendations for the use of WBC Growth factors: American society of clinical oncology clinical practice guideline update,J Clin Oncol,33,3199,3212
SuzukiH,AsakawaA,AmitaniH,NakamuraN,InuiA,Cancer,,2013,-pathophysiology and management,J Gastroenterol,48,574,94
TrobecK,Kerec KosM,Von HaehlingS,SpringerJ,AnkerSD,,2013,Pharmacokinetics of drugs in cachectic patients: A systematic review,PLoS ONE,8,e79603,
AndreaN,PaolaF,MariaCM,MilenaF,,2013,Malnutrition, anorexia and cachexia in cancer patients: A minireview on pathogenesis and treatment,Biomedicine & Pharmacotherapy,67,807,17
LintonA,PondG,ClarkeS,VardyJ,GalskyM,SonpavdeG,,2013,Glasgow prognostic score as a prognostic factor in metastatic castration resistant prostate cancer treated with docetaxel based chemotherapy,Clin Genitourin Cancer,11,423,30
GaWY,KyungJE,SangWK,EunJiN,YoungTK,,2016,Malnutrition identified by the nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma,Nutrition and Cancer,68,772,79
BarretM,MalkaD,AparicioT,DalbanC,LocherC,SabateJM,,2011,Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study,Oncology,81,395,402
PhippenNT,LoweryWJ,BarnettJC,HallLA,LandtC,,2011,Evaluation of the patient-generated subjective global assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study,Gynecol Oncol,123,360,4
YongWC,SeongHJ,MiSA,HyunWL,,2014,Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-Cell lymphoma patients treated with rituximab-CHOP,J Korean Med Sci,29,1493,1500
AlexandreJ,Gross-GoupilM,FalissardB,NguyenML,GornetJM,MissetJL,,2003,Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy,Ann Oncol,14,36,41
ShiotaM,YokomizoA,TakeuchiA,KiyoshimaK,InokuchiJ,,2014,Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer,Support Care Cancer,22,3219,26
SantarpiaL,ContaldoF,,2011,Nutritional screening and early treatment of malnutrition in cancer patients,J Cachex Sarcopenia Muscle,2,27,35
ArrietaO,OrtegaMRM,RodríguezVG,SernaThoméMG,Flores-EstradaD,,2010,Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-smal cell lung cancer treated with Paclitaxel cisplatin chemotherapy: a prospective study,BMC Cancer,10,50,
ChelenzS,GilesD,AbdallahSE,,2012,Pidemiology, management and economic impact of febrile neutropenia in oncology patients receiving route care at a regional UK cancer centre,Ann Oncol,23,1889,93
SmithTJ,BohlkeK,LymanGH,,2015,Recommendations for the use of WBC growth factors: American Society of clinical oncology clinical practice guideline update,J Clin Oncol,33,3199,212
PathakR,GiriS,AryalMR,KarmacharyaP,BhattVR,MartinM,,2015,Mortality, length of stay and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in united states,Support Care Cancer,23,615,17
LymanGH,,2009,Impact of chemotherapy dose intensity on cancer patient outcomes,J Natl Compr Canc Netw,7,99,108
CulakovaE,ThotaR,PoniewierskiMS,KudererNM,WoguAF,,2014,Patterns of nation-wide prospective cohort,Cancer Med,3,434,44
LymanGH,AbellaE,PettengellR,,2014,Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review,Crit Rev Oncol Hematol,90,190,9
TakumiF,HirotsuguK,TateakiN,TakahisaK.,,2017,The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum,Cancer Chemotherpy and Pharmacology,79,1229,37
JenkinsP,ScaifeJ,FreemanS.,,2012,Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer,Ann Oncol,23,1766,71
SuzukiH,AsakawaA,AmitaniH,NakamuraN,InuiA,Cancer,,2013,-pathophysiology and management,J Gastroenterol,48,574,94
TrobecK,Kerec KosM,Von HaehlingS,SpringerJ,AnkerSD,,2013,Pharmacokinetics of drugs in cachectic patients: A systematic review,PLoS ONE,8,e79603,
AndreaN,PaolaF,MariaCM,MilenaF,,2013,Malnutrition, anorexia and cachexia in cancer patients: A minireview on pathogenesis and treatment,Biomedicine & Pharmacotherapy,67,807,17
LintonA,PondG,ClarkeS,VardyJ,GalskyM,SonpavdeG,,2013,Glasgow prognostic score as a prognostic factor in metastatic castration resistant prostate cancer treated with docetaxel based chemotherapy,Clin Genitourin Cancer,11,423,30
GaWY,KyungJE,SangWK,EunJiN,YoungTK,,2016,Malnutrition identified by the nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma,Nutrition and Cancer,68,772,79
BarretM,MalkaD,AparicioT,DalbanC,LocherC,SabateJM,,2011,Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study,Oncology,81,395,402
PhippenNT,LoweryWJ,BarnettJC,HallLA,LandtC,,2011,Evaluation of the patient-generated subjective global assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study,Gynecol Oncol,123,360,4
YongWC,SeongHJ,MiSA,HyunWL,,2014,Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-Cell lymphoma patients treated with rituximab-CHOP,J Korean Med Sci,29,1493,1500
AlexandreJ,Gross-GoupilM,FalissardB,NguyenML,GornetJM,MissetJL,,2003,Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy,Ann Oncol,14,36,41
ShiotaM,YokomizoA,TakeuchiA,KiyoshimaK,InokuchiJ,,2014,Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer,Support Care Cancer,22,3219,26
SantarpiaL,ContaldoF,,2011,Nutritional screening and early treatment of malnutrition in cancer patients,J Cachex Sarcopenia Muscle,2,27,35
ArrietaO,OrtegaMRM,RodríguezVG,SernaThoméMG,Flores-EstradaD,,2010,Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-smal cell lung cancer treated with Paclitaxel cisplatin chemotherapy: a prospective study,BMC Cancer,10,50,
0

Citations

0

Downloads

87

Views